Sinensetin inhibits the movement ability and tumor immune microenvironment of non‐small cell lung cancer through the inactivation of AKT/β‐catenin axis

Documenti analoghi

• Downregulation of lncRNA MIR17HG reduced tumorigenicity and Treg‐mediated immune escape of non‐small‐cell lung cancer cells through targeting the miR‐17‐5p/RUNX3 axis
  di: Guanghua Zheng, et al.
  Pubblicazione: (2024)
• Long noncoding RNA LINC01550 inhibits colorectal cancer malignancy by suppressing the Wnt/β‐catenin signaling pathway
  di: Weiyun Wu, et al.
  Pubblicazione: (2024)
• CLDN6 inhibited cellular biological function of nonsmall cell lung cancer cells through suppressing aerobic glycolysis via the RIP1/ASK1/JNK axis
  di: Hua Guo, et al.
  Pubblicazione: (2024)
• Cancer‐associated fibroblasts derived exosomal LINC01833 promotes the occurrence of non‐small cell lung cancer through miR‐335‐5p ‐VAPA axis
  di: Jie Chen, et al.
  Pubblicazione: (2024)
• Tilianin enhances the antitumor effect of sufentanil on non‐small cell lung cancer
  di: Huixia Chen, et al.
  Pubblicazione: (2024)